Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018193HBVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20013017HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20021008HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20013016HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20062745HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS44020000HTLV-1ENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TCGA Plot Options
Drug Information
GeneOPRK1
DrugBank IDDB00708
Drug NameSufentanil
Target IDBE0000632
UniProt IDP41145
Regulation Type
PubMed IDs8612823; 2467589
CitationsZhu J, Xue JC, Law PY, Claude PA, Luo LY, Yin J, Chen C, Liu-Chen LY: The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor. FEBS Lett. 1996 Apr 15;384(2):198-202.@@Chang HM, Berde CB, Holz GG 4th, Steward GF, Kream RM: Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions. Anesthesiology. 1989 Apr;70(4):672-7.
GroupsApproved; Investigational
Direct ClassificationAnilides
SMILESCCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
PathwaysSufentanil Action Pathway
PharmGKBPA451527
ChEMBLCHEMBL658